Overall, 46% of the respondents correctly identified chronic cough. Of these, allergists/immunologists had the highest ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

A pharmaceutical factory which ceased production earlier this year has been bought by Britain's biggest defence firm. BAE ...

The U.S. Supreme Court declined on Monday to hear a bid by a group of physicians and healthcare providers to revive their ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 248,000 of its own ordinary shares as part ...

A recent study shows adults with cardiovascular disease (CVD) have a higher risk of developing shingles. People who have two ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...

The New York-listed healthcare giant is keen to recoup the £1.2bn it paid to buy the supplier of the electronic patient ...

Architects and microbiologists are exploring whether making buildings hospitable to friendly microorganisms can improve human ...

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

Results from a new retrospective study (VEO-000477) adds to research uncovering a relationship between cardiovascular disease ...

The Trump administration is pushing for single-virus shots for measles, mumps, and rubella. It's an anti-vaccine talking ...